Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.2.0.727
Consolidated Balance Sheets - USD ($)
$ in Millions
Jun. 30, 2015
Dec. 31, 2014
Current assets:    
Cash and cash equivalents $ 1,967 $ 1,610
Premium and related receivables 1,248 912
Short term investments 140 177
Other current assets 483 335
Total current assets 3,838 3,034
Long term investments 1,541 1,280
Restricted deposits 101 100
Property, software and equipment, net 462 445
Goodwill 811 754
Intangible assets, net 148 120
Other long term assets 121 91
Total assets 7,022 5,824
Current liabilities:    
Medical claims liability 2,092 1,723
Accounts payable and accrued expenses 1,004 768
Return of premium payable 289 236
Unearned revenue 68 168
Current portion of long term debt 5 5
Total current liabilities 3,458 2,900
Long term debt 1,139 874
Other long term liabilities 330 159
Total liabilities $ 4,927 $ 3,933
Commitments and contingencies    
Redeemable noncontrolling interests $ 155 $ 148
Stockholders' equity:    
Preferred stock, $0.001 par value; authorized 10,000,000 shares; no shares issued or outstanding at June 30, 2015 and December 31, 2014 0 0
Common stock, $.001 par value; authorized 200,000,000 shares; 124,812,343 issued and 119,087,944 outstanding at June 30, 2015, and 124,274,864 issued and 118,433,416 outstanding at December 31, 2014 0 0
Additional paid-in capital 891 840
Accumulated other comprehensive loss (4) (1)
Retained earnings 1,154 1,003
Treasury stock, at cost (5,724,399 and 5,841,448 shares, respectively) (101) (98)
Total Centene stockholders’ equity 1,940 1,744
Noncontrolling interest 0 (1)
Total stockholders’ equity 1,940 1,743
Total liabilities and stockholders’ equity $ 7,022 $ 5,824